Page last updated: 2024-08-17

quinoxalines and Leukemia, Lymphoblastic, Acute, T Cell

quinoxalines has been researched along with Leukemia, Lymphoblastic, Acute, T Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barata, JT; Brandalise, SR; Cardoso, BA; Laranjeira, AB; Leal, PC; Rodrigues, GO; Silveira, AB; Yunes, JA; Yunes, RA; Zanchin, NI	1

Other Studies

1 other study(ies) available for quinoxalines and Leukemia, Lymphoblastic, Acute, T Cell

Article	Year
PI3K inhibition synergizes with glucocorticoids but antagonizes with methotrexate in T-cell acute lymphoblastic leukemia. Oncotarget, 2015, May-30, Volume: 6, Issue:15 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Drug Interactions; Drug Resistance, Neoplasm; Drug Synergism; Glucocorticoids; Humans; Methotrexate; Mice; Mice, Inbred NOD; Mice, SCID; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Protein Kinase Inhibitors; Quinoxalines; Random Allocation; Signal Transduction; Thiazolidinediones; Xenograft Model Antitumor Assays	2015

Article

Year

PI3K inhibition synergizes with glucocorticoids but antagonizes with methotrexate in T-cell acute lymphoblastic leukemia.

Oncotarget, 2015, May-30, Volume: 6, Issue:15

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Drug Interactions; Drug Resistance, Neoplasm; Drug Synergism; Glucocorticoids; Humans; Methotrexate; Mice; Mice, Inbred NOD; Mice, SCID; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Protein Kinase Inhibitors; Quinoxalines; Random Allocation; Signal Transduction; Thiazolidinediones; Xenograft Model Antitumor Assays

2015